TW001: Phase I data

Data from a pair Dutch Phase I trials in healthy volunteers and ALS patients showed that single and multiple doses of TW001 were well tolerated. Mitsubishi Tanabe Pharma Corp. (Tokyo:4508, Osaka, Jap...